Laminin Gamma 2 (LAMC2)-Targeting F(ab′) 2 for 89 Zr Immuno-PET Imaging of Human NSCLC Xenograft Models
Molecular Pharmaceutics · 06.07.2026 · 23 (7) · 3732-3742
DOI: 10.1021/acs.molpharmaceut.6c00200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 29.05.2026. Verfasst von RenCai Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First People's Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technolo…. Hauptthemen laut MEDLINE: Zirconium, Radioisotopes, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Yunnan Talent Support Program, Open Research Project from the First People?s Hospital of Yunnan Province and Yunnan Clinical Research Center for Respiratory Disease.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The First People's Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, China.
- Department of Nuclear Medicine and PET Center, Huashan Hospital, Fudan University, Shanghai 200040, China.
ORCID-Profile: RenCai Lu
Förderung
- National Natural Science Foundation of China
- Yunnan Talent Support Program
- Open Research Project from the First People?s Hospital of Yunnan Province and Yunnan Clinical Research Center for Respiratory Disease
- Kunming University of Science and Technology and the First People?s Hospital of Yunnan Province Joint Special Project on Medical Research
- Yunnan Provincial Science and Technology Department Social Development Special Project
Zitieren
APA
Lu, R., Zhang, J., Bao, G., Kong, Y., Xv, D., & Wang, S. (2026). Laminin Gamma 2 (LAMC2)-Targeting F(ab′) 2 for 89 Zr Immuno-PET Imaging of Human NSCLC Xenograft Models. Molecular Pharmaceutics, 23(7), 3732-3742. https://doi.org/10.1021/acs.molpharmaceut.6c00200
Vancouver
Lu R, Zhang J, Bao G, Kong Y, Xv D, Wang S. Laminin Gamma 2 (LAMC2)-Targeting F(ab′) 2 for 89 Zr Immuno-PET Imaging of Human NSCLC Xenograft Models. Molecular Pharmaceutics. 2026;23(7):3732-3742. doi:10.1021/acs.molpharmaceut.6c00200
BibTeX
@article{Lu2026,
author = {Lu, RenCai and Zhang, JianFang and Bao, GuangFa and Kong, YanYan and Xv, DongDong and Wang, ShaoBo},
title = {Laminin Gamma 2 (LAMC2)-Targeting F(ab′) 2 for 89 Zr Immuno-PET Imaging of Human NSCLC Xenograft Models},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {7},
pages = {3732--3742},
doi = {10.1021/acs.molpharmaceut.6c00200}
}
EUVIMED